Description     Claims     Drawing  

EP00964563A   [0003] 
WO2006086255A   [0004] 
US20040198727A   [0005] 

Curr. Opin. Cell Biol.   [0002] 
Cell   [0002] 
G2 checkpoint abrogators as anti-cancer drugs   [0003] 
Mol Cancer Ther   [0003]  [0003]  [0109] 
Eur. J. Med. Chem. Chim. Ther.   [0177]